Hutchmed completes rolling submission of NDA to USFDA for fruquintinib
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Ayurveda is one of the most advanced sciences of its times
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
Krsnaa Diagnostics Limited has operationalized one diagnostics center at district hospital Male Akbarpur, Kanpur Dehat, Uttar Pradesh.
Multilateral collaborations will serve to strengthen knowledge sharing to formulate framework for accessible, affordable, and quality healthcare
APAC to see a reduction in imported surgical robotics
Subscribe To Our Newsletter & Stay Updated